Regulacje i polityka gospodarcza · 19/11/2010

Merck Sharp & Dohme Corp. to Receive Exclusive License for Meningococcal Vaccine

The U.S. government has announced its intention to grant an exclusive, revocable license for a meningococcal vaccine to Merck Sharp & Dohme Corp., following the requirements of the Patent and Trademark Office regulations.